You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

CLINICAL TRIALS PROFILE FOR CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Chlorpheniramine Polistirex; Hydrocodone Polistirex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00853190 ↗ Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension Completed Mallinckrodt Phase 1 2003-09-01 The objective of this open-label, randomized, two-period, crossover study was to evaluate the oral bioavailability of the Mallinckrodt extended release test capsule formulation of chlorpheniramine polistirex/hydrocodone polistirex compared to an equivalent oral dose of a commercially available extended release oral suspension of chlorpheniramine polistirex/hydrocodone polistirex (Tussionex® Pennkinetic® Extended Release Oral Suspension, Celltech Pharmaceuticals, Inc.) in a test group of healthy subjects under fed conditions.
NCT00853294 ↗ Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension Completed Mallinckrodt Phase 1 2003-09-01 The objective of this open-label, randomized, two-period, crossover study was to evaluate the oral bioavailability of the Mallinckrodt extended release test capsule formulation of chlorpheniramine polistirex/hydrocodone polistirex compared to an equivalent oral dose of a commercially available extended release oral suspension of chlorpheniramine polistirex/hydrocodone polistirex (Tussionex® Pennkinetic® Extended Release Oral Suspension, Celltech Pharmaceuticals, Inc.) in a test group of healthy subjects under fasting conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Chlorpheniramine Polistirex; Hydrocodone Polistirex

Condition Name

Condition Name for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Intervention Trials
Healthy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Chlorpheniramine Polistirex; Hydrocodone Polistirex

Trials by Country

Trials by Country for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Location Trials
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Chlorpheniramine Polistirex; Hydrocodone Polistirex

Clinical Trial Phase

Clinical Trial Phase for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Clinical Trial Phase Trials
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Chlorpheniramine Polistirex; Hydrocodone Polistirex

Sponsor Name

Sponsor Name for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Sponsor Trials
Mallinckrodt 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Chlorpheniramine Polistirex; Hydrocodone Polistirex
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.